BCLI (Brainstorm Cell Therapeutics, Inc.) Forvard P/E multiplikatori
Brainstorm Cell (BCLI) hujayra mahsulotlarini xavfsiz yetkazib berish uchun kriomaxzanlar tarmog'ini ishlab chiqmoqda. GURU.Markets ma'lumotlari asosida hisoblangan kompaniyaning oldingi P/E koeffitsiyenti va 0.00 ko'rsatkichi millionlab dollar daromad keltira oladigan ALS terapiyasiga nisbatan joriy kutuvlarni tasdiqlaydi. Biroq, daromadning yo'qligi va NurOwn tasdiqlanishi bo'yicha FDA tomonidan rad etilish ehtimoli kapitalning kamayishi bilan bog'liq jiddiy xatarlarni yuzaga keltirmoqda.
BrainStorm Cell Therapeutics Inc. (BCLI) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- biznesning bozor baholash ko'rsatkichlari:
- balans kapitallashuvi haqida ma'lumot:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning xususiy kapitalga nisbati Brainstorm Cell|BCLI - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell|BCLI - Kompaniyaning yig'indi qarzdorligi|Qarzning balans kapitallashuviga nisbati Brainstorm Cell Therapeutics, Inc.|BCLI - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi BrainStorm Cell Therapeutics|Tezkor likvidlik brainstorm-cell.com
- foyda va bozor koeffitsiyentlari statistikasi:
BCLI - Sof daromad|Kelajakdagi foyda Brainstorm Cell|BCLI - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Brainstorm Cell Therapeutics, Inc.|BCLI - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Brainstorm Cell Therapeutics, Inc.|BCLI - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda BrainStorm Cell Therapeutics|BCLI - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi brainstorm-cell.com|BCLI - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Brainstorm Cell
Kompaniyaning jamlanma tahlili:BCLI BrainStorm Cell Therapeutics
ALS bilan kurashish uchun NurOwn hujayra terapiyasining ishlab chiqilishi, platformasining noyobligi tufayli Brainstorm Cell (BCLI) uchun sezilarli fundamental qiymat yaratadi. Bozor kapitalizatsiyasining prognoz qilingan foydaga nisbati, kompaniyaning joriy kutilayotgan P/E ko'rsatkichini aks ettirib, investorlarga choraklik hisobotlarni kutmasdan, aktivning qayta baholanish dinamikasini real vaqt rejimida kuzatish orqali emitentning kelgusidagi muvaffaqiyati uchun to'langan premiumni baholash imkonini beradi.
Brainstorm Cell (BCLI) raqobatchilari
Kelajakdagi narxning foydaga nisbati Biogen (BIIB)|NBIX (Neurocrine) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori RGC (Regencell)|Forvard P/E multiplikatori Axsome Corp AXSM|ACADIA Pharmaceuticals - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati xenon-pharma.com XENE|Viking Therapeutics, Inc. (VKTX) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati SUPN|Kelajakdagi narxning foydaga nisbati Catalyst Pharmaceuticals Inc|Denali Corp (DNLI) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati HRMY (Harmony Biosciences)|Kapitalizatsiyaning kelajakdagi foydaga nisbati BHVN|Kelajakdagi narxning foydaga nisbati Amylyx Pharmaceuticals, Inc. AMLX|Trevi Therapeutics Inc (TRVI) - Prognoz qilingan narx-foyda nisbati|PRAX - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori AVXL (Anavex Life Sciences Corp)|CeriBell, Inc. (CBLL) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Prothena|Prognoz qilingan narxning foydaga nisbati ALEC|ANNX: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori OMER|Prognoz qilingan narxning foydaga nisbati Neurogene Therapeutics NGNE|Forvard P/E multiplikatori ACIU (AC Immune)|voyagertherapeutics.com (VYGR) - Prognoz qilingan narx-foyda nisbati|NMRA - Kelajakdagi narxning foydaga nisbati|SCLX: Kelajakdagi narxning foydaga nisbati|Tevogen Bio Holdings, Inc. (TVGN) - Kelajakdagi narxning foydaga nisbati|ACOG (Alpha Cognition Inc.) - Kelajakdagi narxning foydaga nisbati|CGTX (Cognition Therapeutics) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati IKT|Forvard P/E multiplikatori SAVA|Prognoz qilingan narxning foydaga nisbati assertiotx.com ASRT|Kelajakdagi narxning foydaga nisbati Coya Therapeutics COYA|VistaGen Therapeutics, Inc. - Kelajakdagi narxning foydaga nisbati|Ovid Rx - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati acumenpharm.com ABOS|CervoMed (CRVO) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati ATHE|CLNN (Clene Inc) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati PepGen Corp PEPG|Prognoz qilingan narxning foydaga nisbati JUNS (Jupiter Neurosciences Inc)|Forvard P/E multiplikatori relmada.com (RLMD)|Kelajakdagi narxning foydaga nisbati Annovis Bio ANVS|Kelajakdagi narx-foyda multiplikatori GRCE|AIFF - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Klotho Neurosciences Inc|NRSN: Forvard P/E multiplikatori|RVPH (revivapharma.com) - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati MetaVia Inc.|NRXS: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori HSDT|Forvard P/E multiplikatori passagebio.com (PASG)|Forvard P/E multiplikatori NEUP (Neuphoria Therapeutics)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati minervaneurosciences.com (NERV)|ATHA - Kelajakdagi narxning foydaga nisbati|ADXN (Addex Therapeutics Ltd.) - Narxning kelajakdagi foydaga nisbati|alzamend.com (ALZN) - Kelajakdagi narxning foydaga nisbati|CYCN - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati PTIX|KTTA (Pasithea) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Kelajakdagi narxning foydaga nisbati Cortigent, Inc. (CRGT)|ATXI - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Cara Therapeutics, Inc CARA|Kelajakdagi narx-foyda multiplikatori CHRO|ELYM - Kelajakdagi narxning foydaga nisbati|Intra-Cellular Therapies (ITCI) - Prognoz qilingan narxning foydaga nisbati|LBPH (Longboard Pharmaceuticals, Inc.) - Prognoz qilingan narxning foydaga nisbati|Marinus Pharmaceuticals Inc - Kelajakdagi narx-foyda multiplikatori|NKGN (NKGen) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati NeuroBo Pharma (NRBO)|Forvard P/E multiplikatori SAGE|SNPX - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Trevena TRVN|Vigil Neuroscience Inc. - Kelajakdagi narxning foydaga nisbati|WENA - Kelajakdagi narxning foydaga nisbati|CERE: Kelajakdagi narxning foydaga nisbati
